macular telangiectasia type 1 research hub

TELeMAC - Comparative multicenter randomized study of aflibercept versus placebo in macular telangiectasia type 1

This study looks at how well a medicine called aflibercept (Eylea) works compared to a dummy treatment for a rare eye condition called macular telangiectasia type 1. Researchers want to see if it can improve swelling at the back of the eye and help sight.